Targeting neuroinflammation as a preventive and therapeutic approach for perioperative neurocognitive disorders

Chun Cheng, Hanxi Wan, Peilin Cong, Xinwei Huang, Tingmei Wu, Mengfan He, Qian Zhang, Lize Xiong, Tian LiJournal of Neuroinflammation 2022 · DOI

TL;DR

Perioperative neurocognitive disorders (PND), a common complication after surgery and anesthesia, are increasingly linked to neuroinflammation. This review synthesizes recent research on targeting neuroinflammation with various drugs and approaches as a promising strategy for preventing and treating PND, though more clinical validation is needed.

What Problem Does This Paper Address?

The paper addresses the significant clinical challenge of perioperative neurocognitive disorders (PND), which encompass a range of cognitive impairments occurring around surgical procedures. These disorders, including postoperative delirium and longer-term cognitive dysfunction, negatively impact patient recovery and quality of life. While PND is common, especially in older adults and after major surgeries, there are currently no standardized preventive or therapeutic strategies. The authors highlight the growing evidence suggesting that neuroinflammation—the brain's immune response—plays a critical role in the development and progression of PND, making it a key target for novel interventions.

Methods

This paper is a comprehensive review of preclinical and clinical studies published within the last decade. The authors conducted a literature search using terms like "Perioperative neurocognitive disorder," "Postoperative cognitive dysfunction," and "Anti-inflammatory" in PubMed. They screened 154 articles, with additional articles selected based on their initial findings. The review focuses on studies that investigate the link between neuroinflammation and PND, and explore various anti-neuroinflammatory strategies, including pharmacological agents and non-pharmacological approaches. The authors discuss mechanisms of neuroinflammation and present drug candidates targeting specific pathways and cellular players.

Datasets

Not discussed in the paper. This is a review article, not an empirical study that collects or analyzes new data.

Key Insights and Ideas

  • Neuroinflammation as a Central Player: The core insight is that neuroinflammation isn't just a byproduct of surgery and anesthesia but a critical driver of PND. This understanding shifts the focus from simply managing symptoms to addressing the underlying inflammatory processes in the brain.
  • The BBB as a Gateway: The blood-brain barrier (BBB) is highlighted as a crucial mediator. Surgical trauma can compromise BBB integrity, allowing peripheral inflammatory signals to enter the brain and amplify neuroinflammation, thus exacerbating cognitive decline.
  • Microglia: A Double-Edged Sword: Microglia, the brain's resident immune cells, are central to neuroinflammation. They can adopt both pro-inflammatory and anti-inflammatory phenotypes. The balance between these phenotypes is crucial, and interventions aim to shift this balance towards a protective, anti-inflammatory state.
  • Multiple Pathways to Target: The review identifies several key signaling pathways involved in PND pathogenesis, including the NLRP3 inflammasome pathway, HMGB1/TLR pathway, and non-canonical caspase pathways. Targeting these pathways offers potential therapeutic avenues.
  • Diverse Therapeutic Strategies: The paper showcases a wide array of potential interventions, from established drugs like NSAIDs and anesthetics to emerging strategies like microbiome-based treatments, vagal nerve stimulation, and even natural compounds. This breadth underscores the complexity of PND and the multifaceted approach needed.

Key Results

The review synthesizes findings from numerous studies, indicating that various anti-neuroinflammatory strategies have shown promise in both animal models and some clinical settings.

  • Pharmacological Interventions:
    • Microglia Depletion: Inhibitors like PLX3397 and PLX5622 have shown potential in reducing PND in animal models.
  • Targeting Signaling Pathways: NLRP3/caspase-1 inhibitors and compounds targeting HMGB1/TLR pathways have demonstrated beneficial effects in preclinical studies.
  • Anesthetics and Analgesics: While some anesthetics can induce neuroinflammation, others (like propofol) may be less detrimental. Analgesics like acetaminophen and ibuprofen have shown some protective effects.
  • Alpha-2 Agonists (e.g., Dexmedetomidine): These have shown mixed but promising results in clinical trials for reducing delirium and improving cognitive outcomes, though dose and timing are critical.
  • COX-2 Inhibitors: These have shown potential in reducing early PND incidence.
  • NMDA Antagonists (e.g., Ketamine): Ketamine has shown promise in reducing surgery-induced delirium.
  • Glucocorticoids (e.g., Dexamethasone): These have shown benefits in some clinical trials for preventing PND, but results are inconsistent, with higher doses sometimes showing adverse effects.
  • Non-Pharmacological Approaches:
    • Gut-Brain Axis Modulation: Prebiotics and microbiome-based therapies are being explored for their anti-inflammatory effects via the gut-brain axis.
  • Vagal Anti-inflammatory Reflex: Activating this reflex through specific nutritional interventions shows promise.
  • Electroacupuncture (EA): EA is proposed as a therapeutic strategy for POCD due to its ability to relieve cognitive dysfunction and inhibit neuroinflammation.

Limitations and Future Work

The authors emphasize several key limitations and areas for future research:

  • Need for More Clinical Evidence: While preclinical studies are abundant, more robust, large-scale clinical trials are urgently needed to confirm the efficacy and safety of these anti-neuroinflammatory strategies in humans.
  • Long-Term Effects: The long-term cognitive outcomes and potential side effects of these interventions require further investigation.
  • Specificity of Targets: Given the complex cascade of events in PND, identifying the most effective and specific targets within the neuroinflammatory pathways is crucial for developing truly effective therapies.
  • Brain Region Specificity: Most studies focus on the hippocampus, but PND likely involves multiple brain regions. Future research should consider these broader effects.
  • Model Limitations: Animal models, while valuable, do not fully replicate the complexity of human PND, especially in older adults with comorbidities. More sophisticated models are needed.
  • Marker Selection: The timing and significance of inflammatory marker activation can vary, requiring careful consideration in study design.
  • Concomitant Medications: The influence of other medications, particularly opioids, on PND development needs to be accounted for in clinical trials.

The paper concludes by stressing the profound role of neuroinflammation in PND and the ongoing efforts to translate preclinical findings into effective clinical strategies, highlighting the need for continued research into drug safety, efficacy, and long-term outcomes.

Summary updated

Abstract

Perioperative neurocognitive disorders (PND) is a common postoperative complication associated with regional or general anesthesia and surgery. Growing evidence in both patient and animal models of PND suggested that neuroinflammation plays a critical role in the development and progression of this problem, therefore, mounting efforts have been made to develop novel therapeutic approaches for PND by targeting specific factors or steps alongside the neuroinflammation. Multiple studies have shown that perioperative anti-neuroinflammatory strategies via administering pharmacologic agents or performing nonpharmacologic approaches exert benefits in the prevention and management of PND, although more clinical evidence is urgently needed to testify or confirm these results. Furthermore, long-term effects and outcomes with respect to cognitive functions and side effects are needed to be observed. In this review, we discuss recent preclinical and clinical studies published within a decade as potential preventive and therapeutic approaches targeting neuroinflammation for PND.
BibTeX
@article{cheng2022targeting,
  author = {Chun Cheng and Hanxi Wan and Peilin Cong and Xinwei Huang and Tingmei Wu and Mengfan He and Qian Zhang and Lize Xiong and Tian Li},
  title = {{Targeting neuroinflammation as a preventive and therapeutic approach for perioperative neurocognitive disorders}},
  journal = {Journal of Neuroinflammation},
  year = {2022},
  doi = {10.1186/s12974-022-02656-y},
}
Figure